FNQ HealthPathways: the vital tool for healthcare integration

Overview

Initiative type

Service Improvement

Status

Deliver

Published

June 2025

Summary

The purpose of the project was to evaluate how the HealthPathways initiative is improving the healthcare system in Far North Queensland (FNQ).

January 2025 - November 2025

Implementation sites

Cairns & Hinterland Hospital & Health Service.

Aim

To assess the development, implementation and acceptance of HealthPathways, specifically in Obstetrics and Gynaecology in FNQ.

Outcomes

  • 89% of respondents were confident in identifying red flags and 61% were confident in determining
    when to refer for a pelvic ultrasound.
  • Respondents were less confident with diagnosing the causes and starting medical treatments. 50% used HealthPathways every day or a few times a week (28%) most often during the consultation (72%).
  • About 75% reported that  HealthPathways enables them to manage patients they would have previously referred and also improves the quality of their referrals. 85% of patients had been appropriately tested for iron deficiency anaemia and 70% were referred for an ultrasound prior to  referral.
  • However, only 56% of patients had been prescribed first line medications. 74% of patients were referred for appropriate reasons.

Background

HealthPathways is a decision support tool used in primary care for evidence-based guidelines  on patient management. It is also used as a healthcare services directory containing referral information. The Far North Queensland HealthPathways covers a unique geographical footprint including regional areas of Cairns but also very remote communities in  the Torres Strait Islands and Cape York Peninsula. Local pathways relating to women’s health are consistently among the highest viewed pathways in the Far North Queensland region. The most viewed pathway ‘Antenatal – First Consult’ has been viewed 3016 times  since it was released in 2020. The ‘Heavy Menstrual Bleeding’ pathway has been viewed 793 times since it was released in 2018.

Through collaboration between local primary care and hospital services HealthPathways aims to promote healthcare integration, improve  access to services and improve patient outcomes. Research was needed into whether the implementation of HealthPathways in the region has influenced referral quality, working relationships between clinicians or innovative models of care. The management rate  for HMB in Australian general practice is increasing over time (1).

This is reflected in the fact that HMB is a common reason for referral to Cairns Hospital gynaecology outpatient services. Like other regions of Australia, it was identified there is a large  variation in management of heavy menstrual bleeding in the Cairns region. A need to assess local GP knowledge of and quality of referrals for heavy menstrual bleeding was identified after discussions between the HealthPathways team and the gynaecology department  at the Cairns Hospital.

Methods

The project used a mixed methods approach including quantitative and qualitative data  from literature reviews, surveys and hospital audits. The first phase of the project was conducted in February 2025. It involved conducting a survey and retrospective audit. Eighteen general practice term 1 registrars and medical educators were invited to  participate in a survey to assess their use of the FNQ HealthPathways platform and also their knowledge of HMB assessment and management in primary care. The survey question types included multiple choice, Likert scale and open ended questions.

The clinical  retrospective audit was performed as a snapshot of 2024 HMB referrals to the gynaecology department at Cairns Hospital. Data was collected from 20 referrals of patients who were the most recently reviewed in 2024. These patients had been previously referred  for HMB, triaged and accepted for review. Further, all seven of the referrals for HMB that were rejected in 2024 were also included in the project. The ‘Heavy menstrual bleeding (HMB) clinical care standard’ indicators for local monitoring were used to assess  how well the care in the clinical care standard is being implemented in primary care. Indicators included: Proportion of patients with heavy menstrual bleeding who were tested for iron deficiency and anaemia.

Proportion of patients with heavy menstrual bleeding  who were offered medical management at their first presentation. Evidence of local arrangements to support appropriate referral for investigative pelvic ultrasounds for heavy menstrual bleeding. Evidence of protocols or pathways to ensure timely and appropriate referral of patients with heavy menstrual bleeding (2). Stage two of the project will be conducted after six months. During this time there will be targeted GP education regarding assessment and management of HMB. There will also be promotion of the use of  the FNQ HealthPathways guidelines, including HMB. Data collected at stage two of project will be compared to the baseline data to assess for any change in GP knowledge or referrals regarding HMB. The abstract and project were approved for presentation by the  FNQ Human Research Ethics Committee (Reference 1898 AB).

Discussion

The results showed that the survey respondents were confident in identifying causes and red flags of HMB but less confident in determining when to refer for ultrasound or how to medically manage HMB. This may be because many of the respondents were GP registrars - they have good theoretical knowledge but less clinical experience managing HMB at the start of their GP training. Only 29% knew that hormonal contraception was least likely to contribute to HMB. Hormonal contraception is first-line for treatment of HMB. However, 61% correctly answered that the levonorgestrel IUD is the most effective medical option. All the respondents knew when to appropriately refer to gynaecology. Many respondents use HealthPathways regularly, it often saved them time and it improved patient management and quality of referrals. This may be because many of the respondents were starting training and rely more on point of care tools and guidelines to ensure patients are safely and appropriately assessed and treated. Currently, management of HMB in primary care in the Cairns region appears to be varied.

Most patients are appropriately investigated but it appears that only a minority are prescribed medical treatment at the first presentation for HMB or referred for IUD insertion if appropriate. It is difficult to ascertain from the referrals whether patients are being offered appropriate
treatment or being offered and declining treatment. Many referrals to gynaecology were for significant pathology such as suspicion of cancer or after an unsuccessful trial of medical treatment. However, 37% of referrals were for reasons that most likely could be managed in primary care. Hopefully, with appropriate education, the knowledge and confidence of managing HMB in primary care will improve. Managing patients with HMB appropriately, using tools such as HealthPathways, may mean that many patients may not need to be referred, reducing the pressure on specialist services. And, importantly it ensures that patients receive the right care, at the right time, by the right healthcare professional.

References

1. Ashworth G, Bateson D, Britt H, McGeechan K, Harrison C. Australian Journal of General  Practice. Management of heavy menstrual bleeding in Australian general practice – an analysis of BEACH data. 2021. doi: 10.31128/AJGP-08-20-5570. https://www1.racgp.org.au/getattachment/a5cc67f1-8280-44f8-82ea-21be8419a718/Management-of-heavy-menstrual-bleeding-in-Australi.aspx
2. Australian Commission On Safety And Quality In Health Care. Heavy Menstrual Bleeding – Clinical Care Standard. June 2024. https://www.safetyandquality.gov.au/sites/default/files/2024-06/heavy-menstrual-bleeding-clinical-care-standard-2024.pdf

Key contact

Dr Miranda Hamilton

GP Liaison Medical Officer and Clinical Editor

Torres and Cape Hospital and Health Service Service

Email: miranda.hamilton@health.qld.gov.au